KMT2D and head and neck squamous cell carcinoma: In this study, we demonstrate that KMT2D deficiency activates oncogenic and metabolic signaling pathways, including glycolysis, mTORC1 signaling, and ribosome biogenesis, to promote the aggressive growth of HNSCC.